Catherine Ramsey
Stock Analyst at Baird
(2.65)
# 1,988
Out of 5,245 analysts
58
Total ratings
44.44%
Success rate
6.58%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CSTL Castle Biosciences | Maintains: Outperform | $44 → $43 | $20.15 | +113.40% | 11 | May 7, 2026 | |
| TWST Twist Bioscience | Maintains: Outperform | $50 → $65 | $60.57 | +7.31% | 8 | May 5, 2026 | |
| RVTY Revvity | Maintains: Outperform | $129 → $125 | $96.95 | +28.93% | 7 | May 4, 2026 | |
| NTRA Natera | Maintains: Outperform | $239 → $257 | $203.19 | +26.48% | 7 | Feb 27, 2026 | |
| ILMN Illumina | Maintains: Neutral | $105 → $109 | $144.41 | -24.52% | 7 | Oct 31, 2025 | |
| WAT Waters | Maintains: Outperform | $374 → $352 | $342.37 | +2.81% | 11 | Jul 16, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $448.28 | +48.34% | 2 | Nov 1, 2022 | |
| A Agilent Technologies | Maintains: Outperform | $155 → $160 | $114.96 | +39.18% | 5 | Aug 17, 2022 |
Castle Biosciences
May 7, 2026
Maintains: Outperform
Price Target: $44 → $43
Current: $20.15
Upside: +113.40%
Twist Bioscience
May 5, 2026
Maintains: Outperform
Price Target: $50 → $65
Current: $60.57
Upside: +7.31%
Revvity
May 4, 2026
Maintains: Outperform
Price Target: $129 → $125
Current: $96.95
Upside: +28.93%
Natera
Feb 27, 2026
Maintains: Outperform
Price Target: $239 → $257
Current: $203.19
Upside: +26.48%
Illumina
Oct 31, 2025
Maintains: Neutral
Price Target: $105 → $109
Current: $144.41
Upside: -24.52%
Waters
Jul 16, 2025
Maintains: Outperform
Price Target: $374 → $352
Current: $342.37
Upside: +2.81%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $448.28
Upside: +48.34%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $114.96
Upside: +39.18%